FORUM MERGER II CORP. (FMCI)
Forum Merger II Corp. (FMCI), which previously filed a preliminary extension proxy on January 17th, without a contribution to trust for non-redeemers, filed their definitive proxy tonight, but this time with a $0.033 per month contribution.
By way of background, FMCI initially filed asking for an additional four more months so that their expiration deadline could be moved from February 7, 2020 to June 10, 2020. However, the preliminary filing was absent a contribution to trust for non-redeeming shareholders. In fact, there weren’t even place holders for a contribution.
However, in today’s definitive proxy for their February 7th extension vote, they have stated they will now be contributing a very attractive $0.033 per share for each month. That’s $0.132 total if they need to use all four months. Which, since they haven’t announced a combination yet, is highly likely.
Keep in mind that most SPACs need roughly four months from deal announcement to closing of a transaction, so we’re all now on FMCI “Announcement Watch”. However, this reversal of contribution is a little curious. Plus, it’s an expensive contribution at $660,000 (if no one redeems) for each $0.033 month, or $2.64 million for all four months. They probably could have gotten away with $0.03 per month, so they seem very motivated to protect their trust value. And when cash becomes important, it’s usually because a target requires it or they’re deep in negotiations and a reduced trust value would change FMCI’s posture. FMCI may not have a deal on lock yet, but it’s starting to smell like something interesting is cooking.
Or….FMCI’s got nothin’ and they’re just trying to hang on to their cash. My gut says something is up, but as always, we’ll just have to wait and see.
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...
Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...